The introduction of Retatrutide ZPHC, at a strength of 120mg, is creating considerable excitement within the weight loss community. This innovative dual GIP and GLP-1 target medication seems to offer notable improvements in fat shedding compared to existing therapies. Preliminary clinical data ha